Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
EPHX2 encodes a member of the epoxide hydrolase family. Additionally we are shipping Epoxide Hydrolase 2, Cytoplasmic Proteins (7) and Epoxide Hydrolase 2, Cytoplasmic Kits (1) and many more products for this protein.
Showing 10 out of 81 products:
Human Polyclonal EPHX2 Primary Antibody for ELISA, WB - ABIN4308763
Nelson, Subrahmanyan, Summers, Xiao, Alkayed: Soluble epoxide hydrolase dimerization is required for hydrolase activity. in The Journal of biological chemistry 2013
Results showed that among type 2 diabetic patients, the combined effect of MTHFR (show MTHFR Antibodies) TT and EPHX2 GG or GA + AA genotype has a higher risk of ischemic stroke compared with the control group.
we describe the bacterial expression of the recombinant N-terminal domain of sEH-P and the development of a high-throughput screening protocol using a sensitive and commercially available substrate fluorescein diphosphate. The usability of the assay system was demonstrated and novel inhibitors of sEH-P were identified.
The WT sEH formed a very tight dimer, with a KD/M in the low picomolar range. Only R287Q resulted in a large change of the KD/M However, human tissue concentrations of sEH suggest that it is always in its dimer form independently of the SNP.
The EPHX2 Lys55Arg polymorphism is associated with AKI following cardiac surgery in patients without preexisting CKD
EPHX2 polymorphism , might be important determinant of hydrochlorothiazide treatment in patients with hypertension.
This study meta-analysis results did not show significant associations between the polymorphisms of EPHX2.
EPHX2 Variants are associated with Ischemic Stroke.
Because Epoxide Hydrolase 2 (EPHX2) was identified as a novel AN susceptibility gene, and because its protein product, soluble epoxide hydrolase (sEH), converts bioactive epoxides of polyunsaturated fatty acid (PUFA) to the corresponding diols, lipidomic and metabolomic targets of EPHX2 were assessed to evaluate the biological functions of EPHX2 and their role in AN.
Increased levels of soluble epoxide hydrolase in the brain of depressed patients
Interaction among CYP2C8 (show CYP2C8 Antibodies), EPHX2, and CYP4A11 (show CYP4A11 Antibodies) Gene Variants Significantly Increases the Risk for Ischemic Stroke.
These findings establish sEH in podocytes as a significant contributor to renal function under hyperglycemia. These data suggest that sEH is a potential therapeutic target for podocytopathies
Findings identify soluble epoxide hydrolase (sEH) in podocytes as a contributor to signaling events in acute renal injury and suggest that sEH inhibition may be of therapeutic value in proteinuria.
These data demonstrate that genetic deletion of sEH resulted in an altered oxylipin profile, which may have led to an enhanced CRH (show CRH Antibodies) response.
Deficiency or pharmacological inhibition of sEH protected mice from the lipopolysaccharide-induced decrease in systemic arterial oxygen concentration.
Lungs of Ephx2(-/-) mice had a less pronounced inflammatory response and less autophagy with mild distal airspace enlargement accompanied by restored lung function and steady weight gain
over-expression of sEH enhances A1AR (show ADORA1 Antibodies)-dependent contraction and reduces KATP channel-dependent relaxation in MAs (show MAS1 Antibodies). These results suggest a possible interaction between sEH, A1AR (show ADORA1 Antibodies), and KATP channels in regulating vascular tone.
we identified 31 significantly expressed proteins in mouse hippocampus using proteomics analysis and constructed a protein-protein interaction network associated with EPHX2 gene knockout
The role of soluble epoxide hydrolase in the pathophysiology of depression and resilience to repeated social defeat stress
CYP-eicosanoid profiling also revealed that renal, but not plasma and hepatic, 20-HETE levels were significantly increased in sEH-KO compared to WT mice
Dual inhibition of c-Raf (show RAF1 Antibodies) and soluble epoxide hydrolase by t-CUPM prevents mutant KrasG12D-initiated murine pancreatic carcinoma growth.
AP-1 (show JUN Antibodies) activation is involved in the transcriptional up-regulation of sEH by angiotensin II (Ang II) in endothelial cells, which may contribute to Ang II (show AGT Antibodies)-induced hypertension[soluble epoxide hydrolase ]
This gene encodes a member of the epoxide hydrolase family. The protein, found in both the cytosol and peroxisomes, binds to specific epoxides and converts them to the corresponding dihydrodiols. Mutations in this gene have been associated with familial hypercholesterolemia. Alternatively spliced transcript variants have been described.
epoxide hydrolase 2
, soluble epoxide hydrolase
, Soluble epoxide hydrolase
, bifunctional epoxide hydrolase 2
, epoxide hydratase
, epoxide hydrolase 2, cytosolic
, epoxide hydrolase, soluble
, cytosolic epoxide hydrolase
, epoxide hydrolase 2C